132 related articles for article (PubMed ID: 16208639)
1. Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus.
Costenbader KH; Karlson EW; Gall V; de Pablo P; Finckh A; Lynch M; Bermas B; Schur PH; Liang MH
Arthritis Rheum; 2005 Oct; 53(5):718-23. PubMed ID: 16208639
[TBL] [Abstract][Full Text] [Related]
2. Factors determining participation in prevention trials among systemic lupus erythematosus patients: a qualitative study.
Costenbader KH; Brome D; Blanch D; Gall V; Karlson E; Liang MH
Arthritis Rheum; 2007 Feb; 57(1):49-55. PubMed ID: 17266094
[TBL] [Abstract][Full Text] [Related]
3. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
[TBL] [Abstract][Full Text] [Related]
4. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
Bruce IN
Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing adherence to medications in a group of patients with systemic lupus erythematosus in Jamaica.
Chambers S; Raine R; Rahman A; Hagley K; De Ceulaer K; Isenberg D
Lupus; 2008 Aug; 17(8):761-9. PubMed ID: 18625657
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
[TBL] [Abstract][Full Text] [Related]
7. Raloxifene for postmenopausal women with systemic lupus erythematosus: a pilot randomized controlled study.
Mok CC; To CH; Mak A; Ma KM
Arthritis Rheum; 2005 Dec; 52(12):3997-4002. PubMed ID: 16320346
[TBL] [Abstract][Full Text] [Related]
8. Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study.
Norby GE; Holme I; Fellström B; Jardine A; Cole E; Abedini S; Holdaas H;
Arthritis Rheum; 2009 Apr; 60(4):1060-4. PubMed ID: 19333947
[TBL] [Abstract][Full Text] [Related]
9. Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trials.
Yuen SY; Pope JE
Rheumatology (Oxford); 2008 Sep; 47(9):1367-72. PubMed ID: 18577549
[TBL] [Abstract][Full Text] [Related]
10. Coronary calcium in systemic lupus erythematosus is associated with traditional cardiovascular risk factors, but not with disease activity.
Kiani AN; Magder L; Petri M
J Rheumatol; 2008 Jul; 35(7):1300-6. PubMed ID: 18484694
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM
Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963
[TBL] [Abstract][Full Text] [Related]
12. Why do patients with systemic lupus erythematosus take or fail to take their prescribed medications? A qualitative study in a UK cohort.
Chambers SA; Raine R; Rahman A; Isenberg D
Rheumatology (Oxford); 2009 Mar; 48(3):266-71. PubMed ID: 19151034
[TBL] [Abstract][Full Text] [Related]
13. Adherence to medications in systemic lupus erythematosus.
Koneru S; Kocharla L; Higgins GC; Ware A; Passo MH; Farhey YD; Mongey AB; Graham TB; Houk JL; Brunner HI
J Clin Rheumatol; 2008 Aug; 14(4):195-201. PubMed ID: 18636020
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of infliximab in active SLE: a pilot study.
Uppal SS; Hayat SJ; Raghupathy R
Lupus; 2009 Jul; 18(8):690-7. PubMed ID: 19502264
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study.
Bessant R; Duncan R; Ambler G; Swanton J; Isenberg DA; Gordon C; Rahman A
Arthritis Rheum; 2006 Dec; 55(6):892-9. PubMed ID: 17139666
[TBL] [Abstract][Full Text] [Related]
17. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
Strony J; Hoffman R; Hanson M; Veltri E
Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588
[TBL] [Abstract][Full Text] [Related]
18. Association between dental caries and pneumonia in patients with systemic lupus erythematosus.
Pascual-Ramos V; Hernández-Hernández C; Soto-Rojas AE; Celis-Aguilar E; Sánchez-Guerrero J
J Rheumatol; 2006 Oct; 33(10):1996-2002. PubMed ID: 16960926
[TBL] [Abstract][Full Text] [Related]
19. Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
Fortin PR; Abrahamowicz M; Ferland D; Lacaille D; Smith CD; Zummer M;
Arthritis Rheum; 2008 Dec; 59(12):1796-804. PubMed ID: 19035431
[TBL] [Abstract][Full Text] [Related]
20. Tibolone in postmenopausal women with systemic lupus erythematosus: a pilot study.
Vieira CS; Pereira FV; de Sá MF; Paulo LJ; Martins WP; Ferriani RA
Maturitas; 2009 Mar; 62(3):311-6. PubMed ID: 19193505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
